Buy Opana ER 40mg in UK Online
Opana ER 40mg is an extended-release (ER) formulation of oxymorphone hydrochloride, a strong opioid analgesic that was developed for the management of severe, chronic pain requiring continuous, around-the-clock opioid treatment. The extended-release formulation is designed to release oxymorphone gradually over approximately 12 hours and is not intended for occasional or breakthrough pain. (MedlinePlus)
For readers in the United Kingdom, it is important to know that Opana ER is not licensed or routinely prescribed in the UK. In addition, the branded Opana ER product was voluntarily withdrawn from the U.S. market in 2017 following an FDA request related to public health concerns about misuse and abuse, although generic oxymorphone products may still exist in some markets. (MedlinePlus)
What Is Opana ER 40mg?
Opana ER 40 mg contains:
- Active ingredient: Oxymorphone hydrochloride
- Strength: 40 mg
- Medicine class: Strong opioid (opioid analgesic)
- Dosage form: Extended-release tablet
Oxymorphone is a semi-synthetic opioid that acts on opioid receptors in the brain and spinal cord to reduce the perception of pain.
How Does It Work?
Oxymorphone binds primarily to mu-opioid receptors, changing how the brain and nervous system process pain signals.
This can:
- Reduce severe pain
- Improve comfort in patients with chronic pain
- Support daily functioning when pain is appropriately controlled
Because it affects the central nervous system, it can also cause drowsiness and slow breathing.
Medical Uses
Where available, Opana ER was prescribed for adults with pain that:
- Is severe enough to require continuous opioid treatment
- Is expected to last for a prolonged period
- Has not responded adequately to non-opioid medicines or other therapies
It is not appropriate for:
- Mild pain
- Short-term pain
- Occasional pain
- “As-needed” pain relief
Availability in the UK
Opana ER 40 mg is not licensed or routinely available in the United Kingdom. UK clinicians who determine that long-term opioid therapy is appropriate generally prescribe medicines that are licensed for use in the UK and select them based on the patient’s clinical needs.
Important Safety Information
Extended-release opioid tablets should always be:
- Taken exactly as prescribed.
- Swallowed whole with water.
- Never crushed, chewed, broken, or dissolved.
Damaging an extended-release tablet can release the entire dose immediately, greatly increasing the risk of a potentially fatal overdose. (MedlinePlus)
Common Side Effects
Like other strong opioids, oxymorphone may cause:
- Constipation
- Nausea
- Vomiting
- Drowsiness
- Dizziness
- Dry mouth
- Headache
- Sweating
Constipation is particularly common with opioid medicines and may require preventive measures recommended by a healthcare professional.
Serious Side Effects
Seek emergency medical attention immediately if someone develops:
- Difficulty breathing
- Very slow or shallow breathing
- Extreme sleepiness or inability to wake
- Blue lips or fingertips
- Loss of consciousness
- Severe allergic reaction
These symptoms may indicate an opioid overdose or another life-threatening emergency. (MedlinePlus)
Dependence, Tolerance, and Addiction
Like all strong opioids, oxymorphone carries important risks, including:
- Tolerance, where the medicine becomes less effective over time.
- Physical dependence, where stopping suddenly can cause withdrawal symptoms.
- Opioid use disorder (addiction) in some individuals.
If opioid treatment needs to be stopped after long-term use, the dose is usually reduced gradually under medical supervision.
Drug Interactions
Oxymorphone may interact with:
- Other opioid medicines
- Benzodiazepines
- Sleeping tablets
- Alcohol
- Muscle relaxants
- Other medicines that cause drowsiness
These combinations may increase the risk of excessive sedation, dangerously slowed breathing, coma, and death.
Alcohol
Alcohol should be avoided while taking extended-release opioids because it can substantially increase the risk of:
- Severe drowsiness
- Respiratory depression
- Accidental overdose
(DailyMed)
Driving
Do not drive or operate machinery if oxymorphone makes you:
- Sleepy
- Dizzy
- Less alert
- Unable to concentrate
Driving while impaired by opioid medicines is unsafe and may be illegal.
Pregnancy and Breastfeeding
If you are pregnant, planning a pregnancy, or breastfeeding, discuss opioid treatment with your healthcare professional. Long-term opioid use during pregnancy may cause withdrawal symptoms in a newborn after birth, and oxymorphone may not be suitable during breastfeeding. (MedlinePlus)
Storage
Store opioid medicines:
- In their original packaging
- At room temperature
- Away from heat and moisture
- Securely and out of the sight and reach of children
Return unused tablets to a pharmacy for safe disposal.
Frequently Asked Questions
Is Opana ER 40 mg available in the UK?
No. Opana ER is not licensed or routinely prescribed in the UK.
Can Opana ER be used for sudden pain?
No. Extended-release oxymorphone is intended for continuous management of severe chronic pain, not occasional or breakthrough pain. (MedlinePlus)
Can the tablet be crushed or split?
No. Extended-release tablets must always be swallowed whole because crushing or chewing them can rapidly release the full dose and significantly increase the risk of overdose. (DailyMed)
Is the Opana ER brand still marketed?
No. The original Opana ER brand was withdrawn from the U.S. market in 2017 following an FDA request related to public health concerns. (TIME)
Key Takeaways
Opana ER 40 mg is a high-strength extended-release oxymorphone tablet developed for the long-term management of severe pain requiring continuous opioid therapy. It is not licensed or routinely prescribed in the UK, and the branded Opana ER product has been withdrawn from the U.S. market. Like all strong opioids, it carries significant risks, including constipation, drowsiness, respiratory depression, dependence, addiction, and overdose. It should only be used under the close supervision of a qualified healthcare professional and exactly as prescribed. (MedlinePlus)





Reviews
There are no reviews yet.